medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

1999, Number 3

<< Back Next >>

Rev Mex Patol Clin Med Lab 1999; 46 (3)

Delayed hemolytic transfusion reaction by anti-Kpb (Kel4). Report of the first case of anti-Kpb in Mexico

Sánchez-Girón F, Quintanar-García E, Alcaraz JL, Storry J, Mallory D

Language: Spanish
References: 24
Page: 143-146
PDF size: 75.55 Kb.


ABSTRACT

We report the clinical and laboratory data of a patient who had a delayed hemolytic transfusion reaction caused by anti-Kpb undetectable in pre-transfusion compatibility testing, and a second acute transfusion reaction by transfusion of a packed red cell unit mistakenly identified as compatible. It was necessary to involve of an American reference laboratory and the Rare Donor File for the management of this patient. This case is presented because of the very low incidence of this antibody. Additionally, this is the first time that an anti-Kpb has been identified in Mexico.


REFERENCES

  1. Coombs RRA, Mourant AE, Race RR. In-vivo iso sensitization of red cells in babies with hemolytic disease. Lancet 1946; 1: 264-6.

  2. Lewis M, Anstee DJ, Bird GWG et al. Terminology for red cell surface antigens. Vox Sang 1990; 58: 152-69.

  3. Allen FH Jr., Rosenfield RE. Notation for the Kell blood group system. Transfusion 1961; 1: 305-7.

  4. Allen FH Jr., Lewis SJ. Kp a (Penney), a new antigen in the Kell blood group system. Vox Sang 1957; 2: 81-7.

  5. Allen FH, Lewis SJ, Fudenburg H. Studies on anti Kp-b, a new antibody in the Kell blood group system. Vox Sang 1958;3:1-13.

  6. Race RR, Sanger R. Blood groups in man. 6th Ed. Oxford: Blackwell Scientific Publications, 1975.

  7. Sistema de grupos sanguíneos Kell. En: Walke R, Editor. Manual Técnico, Asociación Americana de Bancos de Sangre. Versión castellana de la 10a. Ed. 1990; cap. 12: 276-279.

  8. Mollison PL. Blood transfusion in clinical medicine. 7th. ed. Blackwell Scientific Publications, 1983: 402-7

  9. Manny N, Levene C, Sela R et al. Autoimmunity and the Kell blood groups: Auto anti-Kpb in a Kp(a+b-) patient. Vox Sang 1983; 45: 252-6.

  10. Puig N, Carbonell F, Mary ML. Another example of mimicking anti-Kpb in a Kp(a+b-) patient. Vox Sang 1986; 51: 57-9.

  11. Beek ML, Marsh WL, Pierce SR et al. Auto anti-Kpb associated with weakened antigenicity in the Kell blood group system: A second example. Transfusion 1979; 19: 197-202.

  12. Seyfried H, Górska B, Maj S et al. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired hemolytic anemia. Vox Sang 1972;23:528-36.

  13. Win N, Kaye T, Damain-Willems C, Chatfield C. Autoimmune hemolytic anemia in infancy with anti-Kpb specificity. Vox Sang 1996; 71:187-8.

  14. Anderson L, White JB, Liles BA, Jack JA. A case of hemolytic disease of the newborn caused by anti-Kpb (Rautenberg). Am J Med Technol 1959; 25: 184-8.

  15. Wright J, Cornwall SM, Matsina E. A second example of hemolytic disease of the newborn due to anti-Kpb. Vox Sang 1965; 10: 218-21

  16. Musclow CE, Abbott D, Tobin SM. Multiple antibody formation in a primigravida: anti-D, anti-C, anti-Kpb. Obstet Gynecol 1982; 59: Supl 10S-2S.

  17. Dacus JV, Spinnato JA. Severe erythroblastosis fetalis secondary to anti-Kpb sensitization. Am J Obstet Gynecol 1984, 150: 888-9.

  18. Gorlin JB, Kelly L. Alloimmunization via previous transfusion places female Kpb negative recipients at risk for having children with clinically significant hemolytic disease of the newborn. Vox Sang 1994; 66: 46-8.

  19. Kohan AI, Reybaud JF, Salamone HJ, Rey JA, Rey CE, Villaravid N, Papa S, Cyrulik Goldztein S, Calahonra R, Sánchez Avalos JC. Management of a severe transfusional problem in a patient with alloantibody to Kpb (K4). Vox Sang 1990; 59: 216-7.

  20. Kumar ND, Martlew VJ. Problems in laboratory investigation of transfusion in patients with antibodies to high frequency antigens (a report of two cases with anti-Kpb). Indian J Pathol Microbiol 1994; 37: 431-4.

  21. Efectos adversos de la transfusión sanguínea. En: Walke R, Editor. Manual Técnico, Asociación Americana de Bancos de Sangre. Versión castellana de la 10a. Ed. 1990; cap. 19: 487-512.

  22. Taddie SJ, Barrasco C, Ness PM. A delayed transfusion reaction caused by anti-K6. Transfusion 1982; 22: 68-9.

  23. Marsh WL, DiNapoli J, Oyen R et al. Delayed hemolytic transfusion reaction caused by the second example of anti-K19. Transfusion 1979; 19: 604-8.

  24. Kohan AI, Niborski RC, Rey JA, Amerise G, Vázquez MI, Zani N, Calahonra R, Binagh. A, Sánchez Avalos J. High dose intravenous immunoglobulin in non-ABO transfusion incompatibility. Vox Sang 1994; 67; 195-8.




2020     |     www.medigraphic.com